Rxo (RXO) Total Non-Current Liabilities (2021 - 2026)

Rxo (RXO) has 6 years of Total Non-Current Liabilities data on file, last reported at $711.0 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 5.58% year-over-year to $711.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $711.0 million (down 5.58% YoY) and the FY2025 annual result came in at $698.0 million, down 5.29% from the prior year.
• Total Non-Current Liabilities grew to $711.0 million in Q1 2026, from $698.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $793.0 million in Q3 2024 to a low of $205.0 million in Q3 2022.
• A 5-year average of $632.9 million and a median of $628.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 241.21% — and 2023, when it retreated 11.59%.
• Tracing RXO's Total Non-Current Liabilities over 5 years: stood at $621.0 million in 2022, then retreated by 11.59% to $549.0 million in 2023, then jumped by 34.24% to $737.0 million in 2024, then dropped by 5.29% to $698.0 million in 2025, then increased by 1.86% to $711.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $711.0 million (Q1 2026), $698.0 million (Q4 2025), and $714.0 million (Q3 2025), per Business Quant data.